Janel Corp (JANL) 财报

Janel Corp. is a holding company, which engages in the provision of integrated logistics and freight forwarding services. The company is headquartered in New York City, New York and currently employs 353 full-time employees. The company went IPO on 2002-03-12. The Company’s Life Sciences segment comprises several wholly owned subsidiaries. The Company’s Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Company’s Manufacturing segment comprises Indco, Inc. (Indco). Indco is a majority-owned subsidiary of the Company that manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Its Logistics segment is a non-asset based, full-service provider of cargo transportation logistics management services including freight forwarding via air, ocean and land-based carriers; customs brokerage services; warehousing and distribution services; trucking and others.